Emirates Biotech, a pharmaceutical polymer specialist, has made a series of appointments to its executive board.
This includes the allocation of Marc Verbruggen to the position of CEO last month, as well as the appointment of François de Bie as Chief Commercial Officer, Aman Kulshrestha as Chief Technology Officer and Margrete L. Wie as Head of Finance.
The new leadership team, which will be situated in Dubai, will bring a high level of expertise and vision to the company, according to Emirates Biotech.
Marc Verbruggen
Marc Verbruggen has been involved in the bioplastics sector for a number of years, and has previously served as CEO of NatureWorks.
Under his leadership, NatureWorks became a global provider of bio-based polymer solutions, doubling its manufacturing capacity and establishing a robust global customer base. Marc’s strategic direction will be pivotal in navigating Emirates Biotech through the dynamic landscape of the biopolymers market.
François de Bie
François de Bie has years of experience in business development and marketing within the plastics industry.
As a former Senior Marketing Director at TotalEnergies Corbion and the former President of European Bioplastics, he has played a significant role in enhancing the acceptance of biopolymers globally. His commercial expertise will be key to driving Emirates Biotech's regional sales and marketing, according to the company.
Aman Kulshrestha
With more than 12 years of experience in biopolymers, Aman Kulshrestha is a renowned expert in production, applications of biopolymers and recycling technologies. Her tenure at NatureWorks and Sulzer has equipped her with the skills to oversee Emirates Biotech’s technological advancements, ensuring the production of high-quality PLA biopolymers that meet the demands of various industries.
Margrete L. Wie
Margrete L. Wie has been appointed Head of Finance to oversee Emirates Biotech financial operations. She has a proven track record in financial and strategic management of complex technology industries in both start-up and mature business environments.
Emirates Biotech recently launched operations and will spearhead the production and marketing of PLA biopolymers across the Middle East, Africa and India, offering a sustainable solution to replace traditional fossil fuel-based plastics.
PLA biopolymers are renewable, recyclable, biodegradable and directly relevant to the goals of a circular economy.
